Disease-Modifying Therapies

Disease-modifying therapies (DMT's) can affect the course of MS. Although not a cure, disease-modifying therapies act to reduce the number and severity of MS relapses. They also reduce the number of new MS lesions. It is not yet known whether these drugs will slow down the rate of disability in the long-term.

Information on all the DMTs that are currently available in Ireland can be found in this table, including administration methods, possible side effects and how the medication is paid for. More detailed information on each medication is available in the information sheets below.


Aubagio

Aubagio is prescribed to adults with relapsing remitting MS.

Avonex

Avonex is the brand name for a disease modifying treatment for people with MS. The active ingredient is interferon beta 1a, which comes in a solution or powder, and is given by injection.

Betaferon

Betaferon (interferon beta-1b) is a type of medicine known as an interferon, which is used to treat MS. Interferons are proteins found naturally in the body, which may help boost the immune system and fight infections.

Copaxone

Copaxone is the brand name for glatiramer acetate injection. Copaxone is a mixture of four amino acids, the natural building blocks of proteins in the body. Copaxone is the first non-steroidal, non-interferon MS drug therapy available to people living with relapsing-remitting MS.

Fampyra

Fampyra is a slow-release oral tablet for the symptomatic treatment of walking impairment in adults with multiple sclerosis.

Gilenya

Gilenya (Fingolimod) is a new type of therapy that can be taken orally rather than by injection or infusion. It is known as a disease modifying therapy (DMT) and targets the immune system to reduce relapses. 

Lemtrada

Lemtrada (alemtuzumab) is an experimental drug treatment (an annual infusion) that is currently being tested in clinical trials for people with relapsing remitting MS. The new marketing name for Alemtuzumab is Lemtrada.

Plegridy

Plegridy can be prescribed for adults with relapsing remitting MS.

Rebif

Rebif belongs to a class of medicines known as interferons. These are natural substances that transmit messages between cells. Rebif is a highly purified soluble protein, which is similar to the natural interferon beta that is produced in the human body. It has been shown to reduce the number and the severity of relapses and to slow the progression of disability in patients with MS

Tecfidera (dimethyl fumarate)

Tecifidera (dimethyl fumarate or DMF) is a drug for treating relapsing-remitting multiple sclerosis (RRMS). 

Tysabri

Tysabri is given to patients with highly active forms of relapsing-remitting MS or those who have failed on other disease-modifying therapies. ‘Highly active’ is defined as two or more disabling relapses in a year and the presence of more lesions on the brain in an MRI scan.

Zinbryta (Daclizumab)

Zinbryta is a disease modifying therapy for relapsing forms of Multiple Sclerosis.

Latest News

More news

What's hot

Trek

Treks 2018

Get active for MS and sign up to trek with us in 2018. Challenge yourself to trek to Everest Base Camp or join us in Jordan or Italy. The choice is yours!

Find out more

Events Calendar

» Our next Event

23 October 2017: Yoga group classes held every Monday for 10 weeks - 1 hour per week. Classes commening 4th September at 11am.

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow